Rifaximin Alfasigma 550 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

rifaximin alfasigma 550 mg film-coated tablets

alfasigma s.p.a - rifaximin - film-coated tablet - 550 milligram(s) - antibiotics; rifaximin

Syntocinon Ampoules 5 IU/ml Concentrate for solution for infusion or Solution for intramuscular injection Ireland - English - HPRA (Health Products Regulatory Authority)

syntocinon ampoules 5 iu/ml concentrate for solution for infusion or solution for intramuscular injection

alfasigma s.p.a - oxytocin - solution for injection/infusion - 5 international unit(s)/millilitre - oxytocin and analogues; oxytocin

Syntocinon Ampoules 10 IU/ml Concentrate for solution for Infusion or solution for intramuscular Injection Ireland - English - HPRA (Health Products Regulatory Authority)

syntocinon ampoules 10 iu/ml concentrate for solution for infusion or solution for intramuscular injection

alfasigma s.p.a - oxytocin - solution for injection/infusion - 10 international unit(s)/millilitre - oxytocin and analogues; oxytocin

ZELNORM- tegaserod tablet United States - English - NLM (National Library of Medicine)

zelnorm- tegaserod tablet

alfasigma usa, inc. - tegaserod (unii: 458vc51857) (tegaserod - unii:458vc51857) - zelnorm is indicated for the treatment of adult women less than 65 years of age with irritable bowel syndrome with constipation (ibs-c). limitations of use - the safety and effectiveness of zelnorm in men with ibs-c have not been established [see clinical studies ( 14 )] . zelnorm is contraindicated in patients with: - a history of myocardial infarction (mi), stroke, transient ischemic attack (tia), or angina [see warnings and precautions ( 5.1 )] - a history of ischemic colitis or other forms of intestinal ischemia [see warnings and precautions ( 5.2 )] - severe renal impairment (egfr< 15 ml/min/1.73 m2 ) or end-stage renal disease [see use in specific populations ( 8.6 )] - moderate and severe hepatic impairment (child-pugh b or c) [see use in specific populations ( 8.7 )] - a history of bowel obstruction, symptomatic gallbladder disease, suspected sphincter of oddi dysfunction, or abdominal adhesions [see adverse reactions ( 6.2 )] - hypersensitivity to tegaserod [see adverse reactions ( 6.2 )] risk summar

Zaditen 1 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

zaditen 1 mg tablets

alfasigma s.p.a - ketotifen fumarate - tablet - 1 milligram(s) - other antihistamines for systemic use; ketotifen

Zaditen 1mg/5ml oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

zaditen 1mg/5ml oral solution

alfasigma s.p.a - ketotifen fumarate - oral solution - 1 mg/5ml - other antihistamines for systemic use; ketotifen

Synacthen 250 micrograms/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

synacthen 250 micrograms/ml solution for injection

alfasigma s.p.a - tetracosactide acetate - solution for injection - 250 mcg/ml microgram(s)/millilitre - acth; tetracosactide

CARNITINE SOLUTION 30% Israel - English - Ministry of Health

carnitine solution 30%

abic marketing ltd, israel - levocarnitine - solution - levocarnitine 30 % - levocarnitine - levocarnitine - systemic and myopathic carnitine deficiency.

LORMYX 200 MG Israel - English - Ministry of Health

lormyx 200 mg

megapharm ltd - rifaximine - film coated tablets - rifaximine 200 mg - rifaximin - rifaximin - • casual treatment of diseases of grown-ups and youngsters from 12 years up, caused by bacteria in the gastrointestinal tract, sensitive to rifaximin:• hepatic encephalopathy • traveller’s diarrhea, caused by not-invasive enteropathogeneous bacteria.• non-complicated diverticular diseases.

FLONORM 200 MG COMPRIMIDOS RECUBIERTOS Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

flonorm 200 mg comprimidos recubiertos

alfasigma s.p.a. - rifaximina - rifaximina....200 mg